Novartis throws Cerulean a lifeline with $5M deal; Porges disses Celgene’s GED-0301
Novartis has come along with a company-saving deal to partner with Cerulean $CERU. Blasted by a recent trial failure, the Waltham, MA-based biotech is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
